You must log in to view this page.

First Tracks Biotherapeutics Inc. – Filings and Transcripts

NASDAQ: TRAX
Share price (11/4/26): $49.04
Market cap (11/4/26): $2.061 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Initial registration of new securities

Prospectus supplement

Prospectus supplement

Ownership Filter

News Filter

Reports Third Quarter 2026 Financial Results and Provides Business Update

Material Definitive Agreement, Financial Statements or Exhibits

Announces $200 Million Private Placement

Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease

Announces Second Quarter 2026 Financial Results and Provides Business Update

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

SEC STAFF ACTION